Imran Eba

Imran Eba is a seasoned professional with extensive experience in venture capital and biotechnology investments. Currently serving as a Partner at Action Potential Venture Capital since August 2013, Imran Eba holds multiple board member positions at various companies including MicroTransponder, Alpheus Medical, Neuspera Medical, Axon Therapies, and SetPoint Medical. Additionally, Imran Eba functions as a Trustee for Hartford International and serves in advisory and mentorship roles with Creative Destruction Lab and Harvard HealthTech. Prior to current endeavors, Imran Eba accumulated significant experience at GlaxoSmithKline from February 2005 to July 2013, leading the establishment of an investment management practice and managing various investment strategies in life sciences. Educationally, Imran Eba is a Chartered Accountant and a graduate of Concordia University.